Exosomes and ground substances: their role in healing

An increase in wound bioburden must be controlled for healing to progress. This session will explain the latest scientific rationale for why this is so important and outline some of the subsequent pathophysiology processes, many of which can be initiated or manipulated by CAMPs, that promote healing

This talk will summarise the rationale for the new nomenclature, explaining how its categories relate to product structure, components and ingredients. It will also overview treatment  goals associated with this advanced technology.

In Europe, CAMPs are less widely used as an advanced wound therapy compared with the US. In Switzerland, interest in this advanced technology is growing. This session will explore the impact that CAMPs are having in a region where it is only recently being incorporated into standard of care

Product selection should be influenced by an awareness of how a CAMP’s category and mode of action will interact with the wound bed to promote healing. This session will explore the science behind this.

20 minute session with 10 min Q&A

Given the popularity of CAMPs for hard-to-heal wounds and complex acute wounds, the logical next step is to consider its use for limb salvage. This begs the question of where CAMPs fit into the reconstructive ladder. This session will explore ways of approaching this and set the scene for an expert panel consensus meeting, whose findings will be published in JWC.

There are a multitude of applications and indications for CAMPs in the operating room and beyond. This session will include case study accounts of the use of CAMPs in complex wounds in acute patients. Attendees will be invited to participate in the discussion, which will include polling on how the challenges outlined in the cases can best be approached.

• CAMPs and reconstructive surgery

• Use on vital structures, like tendon and exposed bone

• Burns

• Traumatic and combat wounds